Emcure Pharmaceuticals Receives ₹57.74 Crore Penalty Orders From Income Tax Department
Emcure Pharmaceuticals Ltd · Others (Uncategorized) · 03 Oct 2026, 2:59 am
Emcure Pharmaceuticals Receives ₹57.74 Crore Penalty Orders From Income Tax Department Emcure Pharmaceuticals has received orders from the Deputy Commissioner of Income Tax, Pune, imposing an aggregate penalty of Rs. 57,73,96,732. The penalty covers FY'15 through FY'21 (AY'16 to AY'22) stemming from ongoing litigation initiated on 27th Dec'23. In response, the company stated it is evaluating appropriate legal remedies, including filing an appeal before the Appellate Authority.
Original exchange filing (PDF)
More announcements from Emcure Pharmaceuticals Ltd
- Intimation of Cancellation of schedule of Analyst / Investor Meeting(s) scheduled on November 16, 2026 · 15 Nov 2026
- Transcript of Earnings Call - Q2 FY27 held on Tuesday, November 03, 2026 at 4:00 p.m. (IST) · 06 Nov 2026
- Intimation of schedule of Analyst/Investor Meeting dated Monday, November 16, 2026 · 06 Nov 2026
- Intimation of schedule of Analyst/Investor Meeting on Monday, November 16, 2026 · 06 Nov 2026
- Audio recording of Earnings Call - Q2 FY27 · 04 Nov 2026
- Presentation on Unaudited Financial Results for the quarter ended September 30, 2026 · 03 Nov 2026
- Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2026 · 03 Nov 2026
- Emcure Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 03 Nov 2026
